Biofil Chemicals & Pharmaceuticals Ltd logo

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM BSE: 524396

₹29.23

+0.22 (0.76%)

Sun, 08 Nov 2026, 08:30 pm

mtf coin illustrationMTF 5xInvest in Biofil Chemicals & Pharmaceuticals Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)47.05
PE Ratio98.25
Dividend0
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Biofil Chemicals & Pharmaceuticals Share Price Live Chart

1 Day

+0.22 (0.76%)

No Result Found

Summary

  • Market Cap (in Cr)

    49.46

  • Net Profit (in Cr)

    2.79

  • P/B

    1.95

  • Sector P/E

    51.09

  • P/E

    15.13

  • EV/EBITDA

    11.21

  • Debt/Equity (Industry)

    0.53

  • Interest Cover (Industry)

    3.44

  • ROCE (Industry)

    3.83

  • RONW (Industry)

    2.94

  • ROE

    -1.14

  • ROCE

    1.26

  • Debt/Equity

    0.09

  • EPS (TTM)

    0.30

  • Dividend Yield

    0

  • Book Value

    13.25

  • Interest Cover

    65

Analysis

all

thumbs up icon

Pros

  • Biofil Chemicals and Pharmaceuticals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Biofil Chemicals and Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Biofil Chemicals and Pharmaceuticals is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (105.8%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 24.4x debt.
thumbs up icon

Cons

  • Unable to evaluate Biofil Chemicals and Pharmaceuticals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Biofil Chemicals and Pharmaceuticals's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • High level of physical assets or inventory.
  • Biofil Chemicals and Pharmaceuticals is not covered by any analysts.
  • Biofil Chemicals and Pharmaceuticals has significant price volatility in the past 3 months.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters46.7946.7946.7946.7946.79
FII00000.00
DII0.080.080.080.080.08
Public53.1353.1353.1353.1353.13
Government00000

Read More

Technical Analysis

RSI

56.32

MACD

-0.22

50 DMA

31.07

200 DMA

32.64

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic37.7133.4231.0529.1326.7624.8420.55
Fibonacci33.4231.7830.7729.1327.4926.4824.84
Camarilla29.8629.4729.0729.1328.2927.8927.50

Pivots Level: Classic

R3

+8.58

37.71

R2

+4.29

33.42

R1

+1.92

31.05

29.13
29.13
Pivot Point
LTP: 30.93

S1

-2.37

26.76

S2

-4.29

24.84

S3

-8.58

20.55

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    29.89

  • 20-EMA

    29.91

  • 30-EMA

    30.17

  • 50-EMA

    30.72

  • 100-EMA

    31.67

  • 200-EMA

    33.50

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 Aug 2026agm
30 May 2026board-meetingsAccounts
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
12 Aug 2025agm
30 Aug 2024agm
23 Aug 2024agmAnnual General Meeting24 Sept 2024
24 Aug 2023agm
20 Aug 2023agmAnnual General Meeting21 Sept 2023
21 Aug 2022agmAnnual General Meeting23 Sept 2022

Read More

Peer Comparison

Biofil Chemicals & Pharmaceuticals Ltd logo

Biofil Chemicals & Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Biofil Chemicals & Pharmaceuticals Ltd About

Biofil Chemicals & Pharmaceuticals manufactures formulations in the form of injectables, eye drops, and dry syrups. The Company offers products that include antibiotics, antianalgesics, diuretics, antimalarial vitamins, antacids, and anti-inflammatory the

Industry

Trading

Founded

1985

Headquarters

CEO

Ketan Shah

Employees

Contact

Website icon

Website

http://www.biofilgroup.net

Email icon

Email

bcplcompliance@gmail.com; biofilchemicals@yahoo.co

Phone icon

Phone

91-731-2426700

Location icon

Location

11/12 Sector E Sanwer Road, Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015

Read More

Biofil Chemicals & Pharmaceuticals Ltd Company History

YearHistory
1985
  • BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED was incorporated as a Private Limited company for manufacturing of pharmaceutical products.
1992
  • The company was converted into a Public Limited Company.
1993
  • The company came out with its first public issue to set up a unit to manufacture formulation based pharmaceutical products.
  • The Company commenced commercial production in its existing formulation division.
2011
  • The registered office of the Company's Registrar and share transfer agent was shifted to Ankit Consultancy Private Ltd.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ORION STOCKS LTDbulkSell8984832.9327 Aug 2026
ORION STOCKS LTDbulkBuy385632.9427 Aug 2026
ORION STOCKS LTDbulkBuy8599232.9927 Aug 2026
IRAGE BROKING SERVICES LLPbulkBuy1454232.6726 Aug 2026
ORION STOCKS LTDbulkBuy17941932.6126 Aug 2026
IRAGE BROKING SERVICES LLPbulkSell14808232.5826 Aug 2026
ORION STOCKS LTDbulkSell3026632.6426 Aug 2026
IRAGE BROKING SERVICES LLPbulkSell1954232.6426 Aug 2026
IRAGE BROKING SERVICES LLPbulkBuy15308232.7626 Aug 2026
ORION STOCKS LTDbulkBuy6178732.4626 Aug 2026

Read More

Biofil Chemicals & Pharmaceuticals Ltd News

Biofil Chemicals concludes 41st AGM via VC

Biofil Chemicals held its 41st AGM on September 23, 2026, via VC/OAVM. Key resolutions included adopting FY26 financials and reappointing directors.

23 Sept 2026

companies

Biofil Chemicals FY26 net profit rises to ₹278.60 crore

Biofil Chemicals reported a net profit of ₹278.60 crore for FY26, a significant increase from ₹55.78 crore in the previous year. Revenue from operations stood at ₹2839.52 crore.

30 May 2026

companies

Biofil Chemicals Board Meet on May 30

Biofil Chemicals and Pharmaceuticals Limited scheduled a board meeting for May 30, 2026, to consider audited financial results for Q4 and FY26. The trading window will open 48 hours post-results declaration.

21 May 2026

companies

Biofil Chemicals Urges Physical Shareholders to Update KYC

Biofil Chemicals and Pharmaceuticals has issued a regulatory intimation urging physical shareholders to mandatorily furnish PAN, KYC, bank account details, and nomination information per SEBI guidelines.

06 May 2026

companies

Biofil Chemicals Declares Non-Applicability of SEBI

Biofil Chemicals and Pharmaceuticals Limited confirms it does not fall under Large Corporate category as on March 31, 2026, making SEBI debt securities circular non-applicable with outstanding borrowing of ₹0.02 crore.

10 Apr 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Biofil Chemicals & Pharmaceuticals Ltd?

    As of 09/11/2026 at 2:00 AM, Biofil Chemicals & Pharmaceuticals Ltd shares are trading at ₹29.23.

  • 2.What is the market cap. of Biofil Chemicals & Pharmaceuticals Ltd?

    As of 09/11/2026, the market capitalization of Biofil Chemicals & Pharmaceuticals Ltd is ₹47.05 crore.

  • 3.When was Biofil Chemicals & Pharmaceuticals Ltd founded?

    Biofil Chemicals & Pharmaceuticals Ltd was founded in 1985.

  • 4.What are the P/E and P/B ratios of Biofil Chemicals & Pharmaceuticals Ltd?

    As of 09/11/2026, Biofil Chemicals & Pharmaceuticals Ltd has a P/E ratio of 98.25 and a P/B ratio of 1.95.

  • 5.How can I buy shares of Biofil Chemicals & Pharmaceuticals Ltd?

    You can buy shares of Biofil Chemicals & Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.Does Biofil Chemicals & Pharmaceuticals Ltd pay dividends?

    No, Biofil Chemicals & Pharmaceuticals Ltd does not pay dividends to eligible shareholders currently.

  • 7.What are the latest financial results of Biofil Chemicals & Pharmaceuticals Ltd?

    For the financial year ended March 2025, Biofil Chemicals & Pharmaceuticals Ltd reported revenue of ₹33.40 crore and a net profit of ₹0.56 crore.

  • 8.What is the Stock symbol of Biofil Chemicals & Pharmaceuticals Ltd?

    BIOFILCHEM is the stock symbol of Biofil Chemicals & Pharmaceuticals Ltd.

  • 9.Who is the CEO of Biofil Chemicals & Pharmaceuticals Ltd?

    The CEO of Biofil Chemicals & Pharmaceuticals Ltd is Ketan Shah.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconbiofil chemicalspharmaceuticals ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800